|
End-of-day quote
Nasdaq Stockholm
|
||
| - SEK | - |
|
| 27/10 | Irlab Therapeutics Set to Obtain US Patent for Parkinson's Disease Drug Candidate | MT |
| 27/10 | Irlab receives positive patent notice in the US for IRL1117 | FW |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +3.19% | +11.31% | +23.28% | +23.39% | +31.90% | +64.28% | +155.66% | +468.59% | +1,842.37% | 1,26300Cr | |
| -0.73% | +3.56% | +5.62% | +6.57% | +32.01% | +44.65% | +83.74% | +67.59% | +136.86% | 66TCr | |
| +1.41% | +3.24% | +13.45% | +17.51% | +29.06% | +35.25% | +106.98% | +156.85% | +422.39% | 52TCr | |
| -1.33% | +0.43% | +15.19% | +11.85% | +21.33% | +53.45% | +67.21% | +8.37% | +77.53% | 39TCr | |
| +2.18% | +2.93% | +3.97% | +14.84% | +42.05% | +73.90% | +45.38% | +70.22% | +152.14% | 37TCr | |
| -1.22% | +3.70% | +13.63% | +6.18% | +20.62% | +32.86% | +56.15% | +72.05% | +90.35% | 31TCr | |
| -0.39% | +8.25% | +17.22% | +20.99% | +0.90% | +12.54% | +34.28% | +47.60% | +207.46% | 29TCr | |
| +1.15% | +6.09% | +14.42% | +20.99% | +42.38% | +56.15% | +78.66% | +122.13% | +231.07% | 25TCr | |
| +3.06% | +9.38% | +15.72% | +31.08% | +39.06% | +42.48% | +112.84% | +160.02% | +130.43% | 21TCr | |
| -0.11% | +2.09% | +6.89% | -12.04% | -18.25% | -15.67% | -62.52% | -25.52% | +123.54% | 18TCr | |
| +1.90% | +1.63% | +8.53% | +22.03% | +22.57% | +23.81% | +0.03% | -30.06% | -1.77% | 17TCr | |
| +3.50% | +6.67% | +10.29% | +17.14% | +23.28% | +31.33% | +51.32% | +201.45% | +617.62% | 14TCr | |
| +1.78% | +1.63% | +1.66% | -4.33% | +15.83% | +35.62% | +21.84% | +6.48% | +22.99% | 13TCr | |
| +1.40% | -0.62% | +10.65% | +16.16% | +21.25% | +22.58% | +116.41% | +377.98% | +669.38% | 12TCr | |
| -0.28% | +6.62% | +12.30% | +6.74% | -3.87% | -8.53% | -8.81% | -11.26% | +10.68% | 11TCr | |
| -0.77% | -3.79% | +3.54% | -3.51% | +0.99% | +4.87% | +31.98% | -5.79% | -8.25% | 9.96TCr | |
| +13.33% | +15.26% | +26.28% | +21.67% | +20.21% | +42.36% | +17.27% | +45.18% | +167.75% | 9.31TCr | |
| -0.47% | +10.80% | +17.35% | +304.45% | +651.85% | +716.35% | +190.97% | -34.24% | - | 8.85TCr | |
| -0.56% | +4.77% | +9.90% | +5.62% | +22.72% | +34.63% | +4.88% | -28.32% | +63.21% | 7.35TCr | |
| Average | +1.26% | +5.36% | +12.10% | +27.75% | +53.47% | +68.57% | +58.12% | +87.86% | +275.32% | 28.73TCr | |
| Weighted average by Cap. | +1.15% | +6.10% | +13.85% | +19.82% | +35.78% | +54.31% | +83.36% | +166.43% | +578.56% |
- Stock Market
- Stocks
- IRLAB A Stock
- Stock
- Sector IRLAB Therapeutics AB
Select your edition
All financial news and data tailored to specific country editions
